CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. High incidence of neurological disorders
4.1.2. Ease of use and portability of brain monitoring devices
4.1.3. Changing lifestyles & growing aging population
4.1.4. Advancements in technology
4.2. Market Restraints & Challenges
4.2.1. Stringent government regulations & shortage of trained professionals
4.2.2. Unfavourable reimbursement policies
4.3. Market Opportunities
4.3.1. Untapped markets in the developing countries
4.3.2. Growing Demand for Non-invasive and Minimally Invasive Devices
4.3.3. Increasing therapeutic applications & clinical trial applications
CHAPTER 5 GLOBAL BRAIN MONITORING MARKET – BY DISEASE TYPE
5.1. Parkinson’s disease
5.2. Traumatic brain injuries
5.3. Epilepsy
5.4. Sleep disorders
5.5. Headache disorders
5.6. Stroke
5.7. Dementia
5.8. Huntington’s Disease
5.9. Others (Autism, Schizophrenia, Williams Syndrome, Landau-Kleffner Syndrome, Depression, Attention-deficit Hyperactivity Disorder, Dyslexia, and Sickle-cell Disease)
CHAPTER 6 GLOBAL BRAIN MONITORING MARKET – BY PRODUCT
6.1. Accessories
6.1.1. Disposable
6.1.2. Reusable
6.2. Devices
6.2.1. MRI scanners
6.2.1. Ct scanners
6.2.1. Pet scanners
6.2.1. Intracranial pressure monitors
6.2.1. Electroencephalography devices
6.2.1. Cerebral oximeters
6.2.1. Sleep monitoring devices
6.2.1. TCD devices
6.2.1. Meg devices
6.2.1. Electromyography devices
CHAPTER 7 GLOBAL BRAIN MONITORING MARKET – BY END-USER
7.1. Hospitals
7.2. Diagnostic Laboratories
7.3. Clinics & Ambulatory Surgical Centers
7.4. Others (Ambulances, Neurological Centers & Research Institutions, Academic Institutions and Home Care Settings)
CHAPTER 8 GLOBAL BRAIN MONITORING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL BRAIN MONITORING MARKET - COMPANY PROFILES
9.1. Advanced Brain Monitoring, Inc.
9.2. CAS Medical Systems, Inc.
9.3. Medtronic PLC.
9.4. Electrical Geodesics, Inc.
9.5. Compumedics Limited
9.6. Siemens Healthineers.
9.7. GE Healthcare.
9.8. Philips Healthcare
9.9. Nihon Kohden Corporation
9.10. Natus Medical Inc.
9.11. BD Biosciences,
9.12. General Electric Company.
9.13. Siemens AG
CHAPTER 10 GLOBAL BRAIN MONITORING MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
